RadNet (RDNT)
(Delayed Data from NSDQ)
$57.28 USD
-1.05 (-1.80%)
Updated Jun 20, 2024 04:00 PM ET
After-Market: $57.60 +0.32 (0.56%) 6:02 PM ET
2-Buy of 5 2
C Value B Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.28 USD
-1.05 (-1.80%)
Updated Jun 20, 2024 04:00 PM ET
After-Market: $57.60 +0.32 (0.56%) 6:02 PM ET
2-Buy of 5 2
C Value B Growth A Momentum B VGM
Zacks News
Buy These 3 Momentum Stocks Backed by the Driehaus Strategy
by Tirthankar Chakraborty
G-III Apparel Group (GIII), RadNet (RDNT) and Hess (HES) have been selected as the momentum picks for the day using the Driehaus strategy.
Don't Overlook These Highly Ranked Medical Stocks as Markets Rise
by Shaun Pruitt
With earnings estimate revisions on the rise for these top medical stocks, they certainly shouldn't be overlooked given their blazing historical performances.
The Zacks Analyst Blog Highlights CareCloud, DaVita, RadNet, SkyWest and American Express
by Zacks Equity Research
CareCloud, DaVita, RadNet, SkyWest and American Express are included in this Analyst Blog.
New Strong Buy Stocks for June 12th
by Zacks Equity Research
RDNT, ESLT, CLS, LNTH and ASBFY have been added to the Zacks Rank #1 (Strong Buy) List on June 12, 2024.
5 Stocks to Gain as Service Side of the Economy Bounces Back
by Tirthankar Chakraborty
With service sector activity rebounding in recent times, it's worth placing bets on stocks such as CareCloud (CCLD), DaVita (DVA), RadNet (RDNT), SkyWest (SKYW) and American Express (AXP).
RadNet, Inc. (RDNT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
RadNet (RDNT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
3 Reasons Why Growth Investors Shouldn't Overlook RadNet (RDNT)
by Zacks Equity Research
RadNet (RDNT) could produce exceptional returns because of its solid growth attributes.
All You Need to Know About RadNet (RDNT) Rating Upgrade to Strong Buy
by Zacks Equity Research
RadNet (RDNT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
RadNet (RDNT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
RadNet (RDNT) delivered earnings and revenue surprises of 177.78% and 2.41%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
McKesson (MCK) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
McKesson's (MCK) fourth-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
RadNet (RDNT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
RadNet (RDNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will RadNet (RDNT) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
RadNet (RDNT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
RadNet (RDNT) Is Up 14.75% in One Week: What You Should Know
by Zacks Equity Research
Does RadNet (RDNT) have what it takes to be a top stock pick for momentum investors? Let's find out.
RadNet (RDNT) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
RadNet (RDNT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Option Care (OPCH) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 10.34% and 2.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Elanco Animal Health Incorporated (ELAN): Can Its 6.2% Jump Turn into More Strength?
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RadNet (RDNT) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
RadNet (RDNT) delivered earnings and revenue surprises of 133.33% and 2.74%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Should Value Investors Buy RadNet (RDNT) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Value Medical Stocks to Buy for Safety Amid Market Volatility
by Indrajit Bandyopadhyay
We have narrowed our search to three value stocks from the Medical sector. These are PHG, RDNT and BVS.
Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and RadNet
by Zacks Equity Research
DaVita, Encompass Health, Option Care Health and RadNet are part of the Zacks Industry Outlook article.
4 Stocks to Buy in a Booming Outpatient Home Health Industry
by Zacks Equity Research
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and RDNT are well-poised to gain.
Best Momentum Stocks to Buy for August 15th
by Zacks Equity Research
DFH, RDNT and PNNT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 15, 2023.
RadNet (RDNT) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
RadNet (RDNT) delivered earnings and revenue surprises of 242.86% and 3.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 260% and 2.03%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
RadNet (RDNT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
RadNet (RDNT) delivered earnings and revenue surprises of -14.29% and 5.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?